Kindred Biosciences reported 79.08M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Adma Biologics ADMA:US $ 174.78M 3.43M
Bayer BAYN:GR 31.94B 506M
Dynavax Technologies DVAX:US $ 852.67M 268.76M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Idexx Laboratories IDXX:US $ 938.04M 63.19M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Kindred Biosciences KIN:US 79.08M 8K
Minerva Neurosciences NERV:US $ 67.44M 7.79M
Novavax NVAX:US $ 2174.18M 180.81M
Phibro Animal Health PAHC:US $ 498.63M 0.28M
Zoetis ZTS:US $ 6682M 366M